PANEXIA® is a genetic test specifically created to detect mutations in genes that result in an increased risk of pancreatic cancer, offering insight about the risk of future hereditary cancers for patients and their families. Via a simple blood test, PANEXIA® analyzes the PALB2 and BRCA2 genes, the two genes most commonly identified in families with hereditary pancreatic cancer. Its results provide information for patients and their family members about the inherited risks of pancreatic cancer as well as breast, ovarian, and other cancers.
Pancreatic Cancer
BRCA2 (Breast cancer 2, early onset), PALB2 (Partner and localizer of BRCA2)